Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China · Delayed Price · Currency is CNY 8.38
-0.44 (-4.99%)
Jul 21, 2026, 12:54 PM CST
SHE:301060 Market Cap
SHE:301060 has a market cap or net worth of 3.51 billion as of July 20, 2026. Its market cap has decreased by -14.04% in one year.
Market Cap
3.51B
Enterprise Value
2.92B
Revenue
1.38B
Ranking
n/a
PE Ratio
238.87
Stock Price
8.38
ChartMarket Cap Chart
Since September 13, 2021, SHE:301060's market cap has decreased from 7.32B to 3.51B, a decrease of -51.96%. That is a compound annual growth rate of -14.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 3.51B | -4.65% |
| Dec 31, 2025 | 3.69B | 1.45% |
| Dec 31, 2024 | 3.63B | -31.73% |
| Dec 29, 2023 | 5.32B | -32.23% |
| Dec 30, 2022 | 7.85B | -43.54% |
| Dec 31, 2021 | 13.91B | 90.09% |
| Sep 13, 2021 | 7.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.95B |
| Beijing Strong Biotechnologies,Inc. | 6.77B |
| Shanghai Runda Medical Technology | 5.92B |
| Maccura Biotechnology Co.Ltd | 5.47B |
| SMO ClinPlus CO.,LTD. | 4.41B |
| Cowealth Medical China | 3.94B |
| Thalys Medical Technology Group | 3.40B |
| Medicalsystem Biotechnology | 3.29B |